Benznidazole is a nitroimidazole antiparasitic agent and a first-line treatment for Chagas disease caused by Trypanosoma cruzi. Simson Pharma's Benznidazole reference standard and impurities support compendial testing for this important neglected-tropical-disease therapy.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Benznidazole Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.